Chip array key technology with exclusive usage rights expands bio solutions portfolio. Initial systems already on the market. Jena/Itzehoe, November 06, 2007 – Analytik Jena AG (Frankfurt, Prime Standard: AJA), the leading provider of analytical measuring systems for food inspection, environmental analysis, medicine and biotechnology, today announced the conclusion of an agreement which gives Analytik […]
Acquisition strengthens presence in genomics research market Roche and NimbleGen Systems Inc. today announced that they have signed a definitive agreement under which Roche will acquire 100% of NimbleGen, a privately held, Madison, Wisconsin, USA-based company active in high-density DNA microarrays. DNA microarrays are a widely used discovery and research tool in pharma research for […]
CAMBRIDGE, Mass.–Helicos BioSciences Corporation (Nasdaq: HLCS – News) announced today that it has priced its initial public offering of 5,400,000 shares of common stock at $9.00 per share. All of the common stock is being offered by the company, and the common stock will trade on the NASDAQ Global Market under the symbol “HLCS.” The […]
Roche and CuraGen today announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the agreement, Roche will pay 454 Life Sciences’ shareholders USD 140 million in cash. In addition to the […]
AUSTIN, Texas and TORONTO, Ontario, Dec. 14 — Luminex Corporation (Nasdaq: LMNX – News) and Tm Bioscience Corporation (TSX: TMC – News) today announced a definitive agreement for Luminex to acquire Tm Bioscience Corporation (TSX: TMC – News), a leader in the commercial genetic testing market. Under the terms of the agreement, each Tm Bioscience […]
November 17, 2006, IJsselstein/Hyderabad – Ocimum Biosolutions, a leading provider of laboratory information management systems (LIMS), bioinformatics solutions, Microarrays and contract research headquartered in Hyderabad, India, has acquired the BioMolecules synthesis business of Isogen Life Science based in The Netherlands. Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said “We are very pleased to have taken […]
SAN DIEGO & HAYWARD, Calif.–Illumina, Inc. (NASDAQ: ILMN – News) and Solexa, Inc. (NASDAQ: SLXA – News) announced today that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger agreement, which was unanimously approved by the Boards of Directors of both companies, Solexa’s […]
PALO ALTO, Calif., Aug. 30, 2006 — Agilent Technologies Inc. (NYSE: A) today announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) applications. This broad license covers microarray applications, including […]
HERCULES, CA–Aug 14, 2006 — Bio-Rad Laboratories, Inc. (AMEX:BIO – News) (AMEX:BIO-B – News), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed a definitive agreement to acquire Ciphergen Biosystems, Inc.’s ProteinChip Systems® and worldwide technology rights to Surface Enhanced Laser Desorption/ Ionization (SELDI-TOF-MS) for […]
PALO ALTO, Calif.,– Agilent Technologies Inc. (NYSE: A)announced the availability of oligo array-based ChIP-on-chip (chromatin immunoprecipitation on a chip) microarrays with a more than sixfold increase in density over previous offerings. The higher density microarrays complement the platform’s superior sensitivity and reproducibility, letting researchers conduct genomic tiling experiments. These microarrays are available in two formats: […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
